(PDF) Incidence of and Risk Factors for Thyroid Dysfunction

Incidence of and Risk Factors for Thyroid Dysfunction During Peginterferon Α and Ribavirin Treatment in Patients With Chronic Hepatitis C

Korean Journal of Internal Medicine - South Korea

doi 10.3904/kjim.2015.30.6.792

Full Text

Abstract

Available in full text

Categories

Internal Medicine

Date

October 30, 2015

Authors

Publisher

Korean Association of Internal Medicine

Related search

Incidence of Thyroid Dysfunction During Interferon Alfa-2b and Ribavirin Therapy in Men With Chronic Hepatitis C

Archives of Internal Medicine

English

Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Associated With Thyroid Dysfunction

Acta Hepatologica Japonica

English

Peginterferon Alfa-2b and Ribavirin Therapy in Kuwaiti Patients With Chronic Hepatitis C Virus Infection

Eastern Mediterranean Health Journal

English

The Combination of Ribavirin and Peginterferon Is Superior to Peginterferon and Placebo for Children and Adolescents With Chronic Hepatitis C

Gastroenterology

Gastroenterology

English

Side Effects of Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis-C

Internal Medicine

Internal Medicine

English

Economic Burden and Complications of Hepatitis C Virus Patients With and Without Peginterferon and Ribavirin Treatment in Turkey

Value in Health

Occupational Health

English

Cost Effectiveness of Interferon or Peginterferon With Ribavirin for Histologically Mild Chronic Hepatitis C

Gastroenterology

English

Depressive Episode Incidence in Patients With Chronic Hepatitis C Treated With Pegylated Interferon and Ribavirin

Arquivos de Gastroenterologia

Gastroenterology

English

Optimum Ribavirin Exposure Overcomes Racial Disparity in Efficacy of Peginterferon and Ribavirin Treatment for Hepatitis C Genotype 1

American Journal of Gastroenterology

Gastroenterology

English